Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

There are plenty of tips on how to lose weight fast without exercise, from sketchy pills to crash diets that do more harm ...

EXPERTS have warned over hundreds rushed to hospital after using weight loss jabs – as half a million Brits now use the ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...

Weight loss jabs are now are now available on the NHS for those with a prescription. But a black market for the in-demand drugs is springing up on social media - the M.E.N's Nicole Wootton-Cane ...

Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...

Semaglutide, a medication originally designed to treat type 2 diabetes, has recently gained significant attention as a weight ...

Besides diabetes, obesity is a major risk factor for hypertension and heart disease, creating what can only be described as a ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

In other news, Novo Nordisk announced the results from its phase 3b STEP UP semaglutide trial today. Specifically, the ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...